在癌症中绘制成长差异化因子-15 (GDF15) 介导的信号通路:了解它在不同癌症类型中的作用
Akhila Balakrishna Rai1, Jalaluddin Akbar Kandel Codi2, Giridhara Prema Suchitha1
1Center for Systems Biology and Molecular Medicine [An ICMR Collaborating Centre of Excellence 2024 (ICMR-CCoE 2024)], Yenepoya Research Centre, Yenepoya (Deemed to Be University), Mangalore, 575018, India.
增长差异化因子-15 (GDF15) 与癌症进展有关. 这项研究绘制了GDF15信号,并发现Vitisifuran B可能抑制GDF15-GFRAL相互作用,提供潜在的癌症治疗.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物信息学是一种生物信息学.
背景情况:
- 增长差异化因子-15 (GDF15) 是一种应激反应性细胞因子,与癌症进展有关.
- 由其受体GFRAL介导的GDF15信号传递,有助于各种癌症.
- 了解GDF15的分子机制对于开发向癌症治疗至关重要.
研究的目的:
- 使用数据挖掘系统地分析癌症中的GDF15介导信号通路.
- 要构建一个详细的GDF15信号通路地图.
- 确定针对GDF15信号的潜在治疗策略.
主要方法:
- 数据挖掘和NetPath标准被用于编译和分析GDF15信号事件.
- 构建了一个GDF15介导的信号通路地图.
- 地图中的蛋白质与癌症数据库进行了交叉引用.
- 进行了分子对接模拟,以确定潜在的抑制剂.
主要成果:
- 创建了一个全面的GDF15信号通路地图,增强对其在癌症中的作用的理解.
- 发现了结直肠和乳腺癌当前蛋白质注释中的差距.
- Vitisifuran B被确定为一种新型抑制剂,通过分子对接阻止GDF15-GFRAL相互作用.
结论:
- 计算方法,包括数据挖掘和分子对接,是研究癌症GDF15信号的强大工具.
- 维蒂西福兰B作为治疗剂在癌症治疗中调节GDF15信号传递的有前途.
- 对维他西B的进一步研究可能会导致新的癌症治疗方法.
更多相关视频
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Differentiation of Common Myeloid Progenitor Cells
Regulation of Angiogenesis and Blood Supply
